Innate-like T cell lineages contribute to host defense against pathogens at mucosal barriers. However, there is a fundamental gap that separates the clinicopathologic relevance of their powerful effector properties from a molecular understanding of their regulation. The major questions arise from the surprising observation that the innate-like effector program is acquired during thymic development, independently of microbial exposure, rather than upon encounter with pathogens. The research has crystallized around the recent finding that the innate-like effector program is directed by a novel transcription factor, promyelocytic leukemia zinc factor (PLZF), which is also responsible for a subset of human leukemias. The long-term goal of these studies is to understand in molecular details the development and the functional program of innate-like T cells. The objective of this application is to define the mechanisms by which PLZF enables the effector properties of innate-like T cells. Our central hypothesis is that PLZF directly or indirectly regulates critical transcription factors that separately or together activate different arms of this effector program. The rationale for thi project is that it will provide unprecedented insight into the molecular interactions that regulate the differentiation of effector programs and, in turn, will allow manipulation of these processes for therapeutic benefit. The proposed hypothesis will be tested by pursuing the following specific aims: 1) to characterize the target genes bound by PLZF, and the resulting changes in epigenetic marks and transcriptional program;2) to characterize the specific role of key transcription factors in differentiating the effector program. While each aim focuses on different approaches, the data will be integrated to develop a model of the transcriptional network regulating the innate-like effector program. The proposal is innovative because it explores the novel idea that a master transcription factor directs the innate-like effector program, which would signal a major shift in our understanding of the biology of innate-like effector T cells. The proposed research is significant because it will enhance our understanding of lymphocyte effector programs and link specific transcription factors to different arms of this program. The concepts and tools developed will make it possible to develop agents that target distinct components of effector programs and, ultimately, to enhance immunity to a range of microbial pathogens.

Public Health Relevance

The proposed research will provide a molecular understanding of the mechanisms that control the early phase of immune responses to microbial organisms at mucosal barriers. It is relevant to public health because discovery of these mechanisms allow development of means or agents to prevent or correct defects in disease and to enhance immunity to pathogens. Thus, this work will directly support the overall NIH mission of developing fundamental knowledge that will help reduce the burden of human disease and promote the NIAID goals of improving immunity to infection and eradicating infectious diseases.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Miller, Lara R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Schools of Medicine
United States
Zip Code
McDonald, Benjamin D; Bunker, Jeffrey J; Ishizuka, Isabel E et al. (2014) Elevated T cell receptor signaling identifies a thymic precursor to the TCR??(+)CD4(-)CD8?(-) intraepithelial lymphocyte lineage. Immunity 41:219-29
Constantinides, Michael G; McDonald, Benjamin D; Verhoef, Philip A et al. (2014) A committed precursor to innate lymphoid cells. Nature 508:397-401
Mathew, Rebecca; Mao, Ai-ping; Chiang, Andrew H et al. (2014) A negative feedback loop mediated by the Bcl6-cullin 3 complex limits Tfh cell differentiation. J Exp Med 211:1137-51
Constantinides, Michael G; Bendelac, Albert (2013) Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 25:161-7
Bai, Li; Constantinides, Michael G; Thomas, Seddon Y et al. (2012) Distinct APCs explain the cytokine bias of ýý-galactosylceramide variants in vivo. J Immunol 188:3053-61
Seiler, Michael P; Mathew, Rebecca; Liszewski, Megan K et al. (2012) Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 13:264-71
Scanlon, Seth T; Thomas, Seddon Y; Ferreira, Caroline M et al. (2011) Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med 208:2113-24
Thomas, Seddon Y; Scanlon, Seth T; Griewank, Klaus G et al. (2011) PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 208:1179-88
Savage, Adam K; Constantinides, Michael G; Bendelac, Albert (2011) Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling. J Immunol 186:5801-6
Constantinides, Michael G; Picard, Damien; Savage, Adam K et al. (2011) A naive-like population of human CD1d-restricted T cells expressing intermediate levels of promyelocytic leukemia zinc finger. J Immunol 187:309-15

Showing the most recent 10 out of 34 publications